Clinical Development Medical Director - EMEA / UK at Abata Therapeutics

United Kingdom

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Autoimmune DiseasesIndustries

Requirements

MD, DO, or equivalent medical degree required; board certification in a relevant specialty preferred
Minimum 5–8 years of experience in the biopharmaceutical industry, with at least 3 years in a medical affairs or clinical development role
Experience in rare diseases and/or autoimmunology strongly preferred
Proven ability to interpret and communicate complex clinical data to diverse audiences
Strong interpersonal and communication skills, with a collaborative and proactive approach
Ability to thrive in a dynamic environment
Located in the United Kingdom

Responsibilities

Serve as a subject matter expert on the company’s pipeline assets, providing deep clinical and scientific insights
Support the development and execution of global medical affairs strategies, including evidence generation, scientific communications, and external engagement
Contribute to the development of medical education materials, scientific publications, and congress presentations
Collaborate with Medical Science Liaisons (MSLs) to ensure scientific alignment and support field medical activities
Participate in the planning and execution of advisory boards and KOL engagement initiatives
Act as a key liaison between Medical Affairs and Clinical Development, ensuring alignment on clinical trial design, data interpretation, and lifecycle planning
Provide medical input into clinical protocols, investigator brochures, and regulatory documents as needed
Support the design and execution of investigator-initiated studies (IIS), real-world evidence (RWE) programs, and post-marketing studies
Collaborate with cross-functional teams to identify data gaps and develop strategies to address them
Work closely with Regulatory, Commercial, Market Access, and other internal stakeholders to ensure scientific consistency and strategic alignment
Contribute to launch readiness and lifecycle management planning

Skills

Clinical Development

Medical Affairs

Autoimmunology

Rare Diseases

Clinical Trials

Principal Investigator Relationships

Scientific Leadership

Pipeline Advancement

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free